LASIX 40 MG TABLETS 40 Milligram Írland - enska - HPRA (Health Products Regulatory Authority)

lasix 40 mg tablets 40 milligram

sanofi-aventis ireland limited t/a sanofi - furosemide - 40 milligram

Maalox 200mg/175mg per 5ml Oral Suspension Írland - enska - HPRA (Health Products Regulatory Authority)

maalox 200mg/175mg per 5ml oral suspension

sanofi-aventis ireland limited t/a sanofi - magnesium hydroxide; aluminium hydroxide - oral suspension - 200mg/175 mg/5ml - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Maalox Plus 200 mg/175 mg/25 mg Oral Suspension Írland - enska - HPRA (Health Products Regulatory Authority)

maalox plus 200 mg/175 mg/25 mg oral suspension

sanofi-aventis ireland limited t/a sanofi - aluminium hydroxide; magnesium hydroxide; simeticone - oral suspension - 200 mg/175 mg/25 mg/5ml - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Solpadol 500 mg/30 mg Effervescent Tablets Írland - enska - HPRA (Health Products Regulatory Authority)

solpadol 500 mg/30 mg effervescent tablets

sanofi-aventis ireland limited t/a sanofi - paracetamol; codeine phosphate hemihydrate - effervescent tablet - 500mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Suprecur 150 micrograms/ metered dose Nasal Spray, solution Írland - enska - HPRA (Health Products Regulatory Authority)

suprecur 150 micrograms/ metered dose nasal spray, solution

sanofi-aventis ireland limited t/a sanofi - buserelin - nasal spray, solution - 150 microgram(s) - gonadotropin releasing hormone analogues; buserelin

SUPREFACT 100 Mcg/Dose Nasal Spray Solution Írland - enska - HPRA (Health Products Regulatory Authority)

suprefact 100 mcg/dose nasal spray solution

sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues

Suprefact 1 mg/ml Solution for Injection Írland - enska - HPRA (Health Products Regulatory Authority)

suprefact 1 mg/ml solution for injection

sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin

Tarivid IV 2 mg/ml Solution for Infusion Írland - enska - HPRA (Health Products Regulatory Authority)

tarivid iv 2 mg/ml solution for infusion

sanofi-aventis ireland limited t/a sanofi - ofloxacin - solution for infusion - 2 milligram(s)/millilitre - fluoroquinolones; ofloxacin

MAALOX SACHETS 460/400 Milligram Oral Suspension Írland - enska - HPRA (Health Products Regulatory Authority)

maalox sachets 460/400 milligram oral suspension

sanofi-aventis ireland limited t/a sanofi - aluminium oxide hydrated, magnesium hydroxide - oral suspension - 460/400 milligram - combinations - for the relief of the symptoms of dyspepsia

LIFSAR PULMOJET 50/500 Microgram Powder for Inhalation Írland - enska - HPRA (Health Products Regulatory Authority)

lifsar pulmojet 50/500 microgram powder for inhalation

sanofi-aventis ireland limited t/a sanofi - salmeterol xinafoate, fluticasone propionate - powder for inhalation - 50/500 microgram - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics - adrenergics, inhalants; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - lifsar pulmojet is indicated for the symptomatic treatment of adults with chronic obstructive pulmonary disease (copd) with a fev1 < 60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations and who have significant symptoms despite regular bronchodilator therapy.